Elicio Therapeutics (ELTX) EPS (Basic) (2020 - 2026)
Elicio Therapeutics' (ELTX) quarterly EPS (Basic) came in at -$0.56 in Q2 2026, up 11.73% on a YoY basis from -$0.5 in Q2 2025, and up 6.68% quarter-over-quarter from -$0.6 in Q1 2026.
Powered by 
Analysis
Elicio Therapeutics (ELTX) EPS (Basic) (2020 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has reported EPS (Basic) for 7 consecutive years, with -$0.56 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 11.73% year-over-year to -$0.56; the trailing twelve-month figure through Jun 2026 stood at -$2.03 (up 27.39% YoY), and the FY2025 full-year result was -$2.54, up 31.87% from the prior year.
- EPS (Basic) grew to -$0.56 in Q2 2026 per ELTX's latest filing, from -$0.6 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.5 in Q3 2025 and bottomed at -$4.83 in Q1 2022.
- Historically, EPS (Basic) has averaged -$1.53 across 5 years, with a median of -$1.05 in 2024.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) tumbled 138.54% in 2022, then jumped 64.77% in 2024.
- Over 5 years, EPS (Basic) stood at -$2.0 in 2022, then climbed by 7.69% to -$1.84 in 2023, then surged by 39.04% to -$1.12 in 2024, then jumped by 46.65% to -$0.6 in 2025, then rose by 7.24% to -$0.56 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.56, -$0.6, and -$0.6 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Elicio Therapeutics | 40.60 Mn | 17.10 Mn | - | -0.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.56 |
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.60 |
| Sep 30, 2025 | -0.50 |
| Jun 30, 2025 | -0.63 |
| Mar 31, 2025 | -0.83 |
| Dec 31, 2024 | -1.12 |
| Sep 30, 2024 | -0.76 |
| Jun 30, 2024 | -0.96 |
| Mar 31, 2024 | -0.99 |
| Dec 31, 2023 | -1.84 |
| Sep 30, 2023 | -1.26 |
| Jun 30, 2023 | -2.73 |
| Mar 31, 2023 | -2.70 |
| Dec 31, 2022 | -2.00 |
| Sep 30, 2022 | -2.27 |
| Jun 30, 2022 | -2.44 |
| Mar 31, 2022 | -4.83 |
| Dec 31, 2021 | 5.18 |
| Sep 30, 2021 | -5.28 |